Pandemic Drives Surge In Hydroxychloroquine Demand: An Emerging Driver Transforming The Hydroxychloroquine Market Landscape

The Hydroxychloroquine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Hydroxychloroquine Market?
The hydroxychloroquine market has experienced solid growth in recent years. It will grow from $2.07 billion in 2024 to $2.22 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. The growth is linked to the rising prevalence of malaria, growing awareness of hydroxychloroquine, its widespread availability, and its use in treating autoimmune diseases.

The hydroxychloroquine market is expected to expand strongly, hitting $2.86 billion by 2029 at a CAGR of 6.6%. Factors driving growth include wider therapy applications, increased healthcare funding, and a rise in chronic patients. Trends include drug repurposing, biotech advances, equity in health access, and environmental sustainability.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3235

What Are the Different Hydroxychloroquine Market Segments?
The hydroxychloroquine market covered in this report is segmented -

1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Other Drug Activity
2) By Formulation: Tablets, Injection
3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Specialty Drug Stores, Retail Pharmacy

Subsegments:
1) By Anti-Malarial Drug: Treatment Of Malaria, Prophylaxis For Malaria
2) By Anti-Rheumatic Drug: Treatment Of Rheumatoid Arthritis, Treatment Of Juvenile Idiopathic Arthritis
3) By Lupus Suppressant Drug: Treatment Of Systemic Lupus Erythematosus
4) By Anti COVID-19 Drug: Treatment Of COVID-19 Symptoms
5) By Other Drug Activity: Treatment Of Other Autoimmune Disorders, Additional Off-label uses

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3235&type=smp

What Are the Primary Drivers Shaping the Hydroxychloroquine Market?
The growing number of COVID-19 cases has led to a rise in the demand for hydroxychloroquine. Its increasing usage in the treatment of COVID-19 patients and ongoing clinical trials have fueled this demand. The U.S. FDA authorized emergency use of hydroxychloroquine for hospitalized patients or those enrolled in clinical trials. According to the World Health Organization (WHO) as of September 21, 2023, there were 770,778,396 confirmed COVID-19 cases globally, with 6,958,499 deaths. Countries such as the U.S., Brazil, Russia, the UK, India, and Spain are heavily impacted by the virus. This surge in COVID-19 cases continues to drive the demand for hydroxychloroquine, increasing revenues for the hydroxychloroquine market.

Which Companies Are Leading in the Hydroxychloroquine Market?
Major companies operating in the hydroxychloroquine market include Bayer AG, Dr. Reddy's Laboratories Ltd., Zydus Group, Ipca Laboratories Ltd., Wallace Pharma, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Novartis AG, Intas Pharmaceuticals Ltd., Lupin Limited, Shanghai Zhongxi Sanwei Pharmaceutical Co. Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals plc, Sandoz International GmbH, Cipla Limited, Shenhua Pharmaceutical Co. Ltd., Sanofi S.A., Macleod Pharmaceuticals Ltd., McW Healthcare, Laurus Labs, TAJ Pharmaceuticals, Wuhan Wuyao Pharmaceutical Co. Ltd., MAAN Medex, Cinkate Corporation, Concordia Healthcare, Pfizer Inc., Cadila Pharmaceuticals, Hetero Drugs Ltd., Jubilant Generics Limited, Alembic Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma USA Inc., Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Unichem Laboratories Ltd., Wockhardt Limited, Emcure Pharmaceuticals Ltd., Strides Pharma Science Ltd., Indoco Remedies Ltd.

What Are the Major Trends Shaping the Hydroxychloroquine Market?
Side effects associated with hydroxychloroquine are anticipated to limit its market growth. The drug has been linked to serious heart rhythm problems, particularly when used outside of hospital settings. In January 2022, the U.S. Food and Drug Administration (FDA) issued a warning about the potential risks of using hydroxychloroquine for COVID-19 treatment, which could limit its use in non-clinical settings and restrict market growth.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hydroxychloroquines-global-market-report

What Are the Top Revenue-Generating Geographies in the Hydroxychloroquine Market?
The countries covered in the hydroxychloroquine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hydroxychloroquine Market?
2. What is the CAGR expected in the Hydroxychloroquine Market?
3. What Are the Key Innovations Transforming the Hydroxychloroquine Industry?
4. Which Region Is Leading the Hydroxychloroquine Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.